FTC seeks public comment on Cardinal Health nuclear pharmacy sales to Patient Care Infusion
The FTC is seeking public comment on Cardinal Health’s application to sell its former nuclear pharmacy assets to Patient Care Infusion. Cardinal is required to sell these assets–located in Las Vegas, Albuquerque, and El Paso–under the 2011 settlement with the FTC for its acquisition of three nuclear pharmacies from Biotech.
Public comments on the sale will be accepted until March 26, 2012.
Source: FTC Press Release
Related Content: Reviving Competition in Healthcare Markets: The Use of Section 5 of the FTC Act (David Balto)
Featured News
Judge Mehta Questions Both Sides in Landmark Google Antitrust Case
May 2, 2024 by
CPI
FCC Urges Urgent Funding for Removal of Chinese Telecom Equipment from U.S. Networks
May 2, 2024 by
CPI
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
May 2, 2024 by
CPI
South Korea’s Antitrust Regulator Greenlights K-Pop Powerhouse Deal
May 2, 2024 by
CPI
Exxon’s Pioneer Purchase Approved, Former CEO Barred from Board
May 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI